Stock PCYN PROCYON CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Procyon Corporation

Equities

PCYN

US7428063009

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 15:38:32 2024-06-03 EDT 		5-day change 1st Jan Change
0.2532 USD +26.62% Intraday chart for Procyon Corporation 0.00% +48.56%
05-24 Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
02-22 Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 1.373 1.796 1.925 3.013 3.801 2.022
Enterprise Value (EV) 1 0.9515 1.352 1.339 2.352 3.454 1.594
P/E ratio -5.02 x 180 x 23.8 x 4.14 x -15.7 x -25 x
Yield - - - - - -
Capitalization / Revenue 0.34 x 0.43 x 0.44 x 0.64 x 0.78 x 0.43 x
EV / Revenue 0.24 x 0.32 x 0.31 x 0.5 x 0.71 x 0.34 x
EV / EBITDA 5.44 x 9.03 x 6.47 x 6.39 x -17.4 x -35.8 x
EV / FCF 11.6 x -25.4 x 18.9 x 10.2 x -11.6 x 6.93 x
FCF Yield 8.59% -3.93% 5.28% 9.79% -8.63% 14.4%
Price to Book 0.72 x 0.93 x 0.94 x 1.07 x 1.5 x 0.81 x
Nbr of stocks (in thousands) 8,077 8,087 8,087 8,087 8,087 8,087
Reference price 2 0.1700 0.2221 0.2380 0.3725 0.4700 0.2500
Announcement Date 18-09-27 19-09-30 20-10-06 21-10-08 22-09-28 23-09-28
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 4.02 4.191 4.334 4.72 4.842 4.687
EBITDA 1 0.1749 0.1497 0.207 0.3681 -0.199 -0.0446
EBIT 1 0.1271 0.0971 0.153 0.3248 -0.2372 -0.0974
Operating Margin 3.16% 2.32% 3.53% 6.88% -4.9% -2.08%
Earnings before Tax (EBT) 1 0.1276 0.0993 0.1601 0.8319 -0.2354 -0.0654
Net income 1 -0.2557 0.0272 0.1117 0.7676 -0.2098 -0.0502
Net margin -6.36% 0.65% 2.58% 16.26% -4.33% -1.07%
EPS 2 -0.0339 0.001233 0.0100 0.0900 -0.0300 -0.0100
Free Cash Flow 1 0.0817 -0.0532 0.0706 0.2302 -0.2981 0.23
FCF margin 2.03% -1.27% 1.63% 4.88% -6.16% 4.91%
FCF Conversion (EBITDA) 46.71% - 34.13% 62.52% - -
FCF Conversion (Net income) - - 63.27% 29.98% - -
Dividend per Share - - - - - -
Announcement Date 18-09-27 19-09-30 20-10-06 21-10-08 22-09-28 23-09-28
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.42 0.44 0.59 0.66 0.35 0.43
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.08 -0.05 0.07 0.23 -0.3 0.23
ROE (net income / shareholders' equity) -11.8% 1.33% 5.29% 30% -7.57% -1.9%
ROA (Net income/ Total Assets) 3.12% 2.53% 3.64% 5.75% -3.67% -1.65%
Assets 1 -8.191 1.075 3.069 13.36 5.71 3.041
Book Value Per Share 2 0.2300 0.2400 0.2500 0.3500 0.3100 0.3100
Cash Flow per Share 2 0.0300 0.0400 0.0800 0.1500 0.0900 0.0600
Capex 1 0.05 0.03 0.02 0.07 0.08 0.18
Capex / Sales 1.16% 0.69% 0.53% 1.38% 1.71% 3.84%
Announcement Date 18-09-27 19-09-30 20-10-06 21-10-08 22-09-28 23-09-28
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PROCYON CORPORATION Stock Procyon Corporation
+48.56% 2.06M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PCYN Stock
  4. Financials Procyon Corporation